ENGINEERED SAFETY IN CELL THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20250025506A1
SERIAL NO

18819922

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to compositions and methods for treating cancer. For example, a modified cell may include a polynucleotide comprising an NFAT promoter, a nucleotide sequence encoding therapeutic agent, and a nucleotide sequence encoding a VHL-interaction domain of HIF1α, wherein the therapeutic agent comprises, for example, IL-12, IL-6, and/or IFNγ.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD190 ELGIN AVENUE GEORGE TOWN KY1-9008
INNOVATIVE CELLULAR THERAPEUTICS INC1405 RESEARCH BOULEVARD SUITE 210 ROCKVILLE MD 20850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cao, Zhiyuan Rockville, US 51 224
Pu, Chengfei Shanghai, CN 53 220
Wu, Zhao Rockville, US 109 362
Xiao, Lei Rockville, US 199 885

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation